The effect of cinnopar (teriparatide) in post-menopausal women with osteoporosis
Phase 1
- Conditions
- Osteoporosis.Osteoporosis in postmenopausal women
- Registration Number
- IRCT2016083029603N1
- Lead Sponsor
- Vice Chancellor for Research, Mazandaran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
Postmenopausal women (aged 45 to 75 years old) diagnosed with osteoporosis by densitometry via Dexa(dual energy Xray absorptiometry); who do not have any history of treatment for osteoporosis; and consent to participate in the study were recruited into the study.
Exclusion criteria: Women with a history of taking corticosteroids or any other medications which cause osteoporosis ; hyperparathyroidism.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bone density. Timepoint: Before treatment and six months after treatment. Method of measurement: densitometry test through Dexa(dual energy Xray absorptiometry.;Serum levels of calcium. Timepoint: Before treatment and six months after treatment. Method of measurement: blood test.;Phosphor level. Timepoint: Before treatment and six months after treatment. Method of measurement: blood test.
- Secondary Outcome Measures
Name Time Method Fractures. Timepoint: One year. Method of measurement: Radiography.